155 related articles for article (PubMed ID: 8417373)
1. Human IgG3 is decreased and IgG1, IgG2 and IgG4 are unchanged in molecular size by mild reduction and reoxidation without any major change in effector functions.
Michaelsen TE; Naess LM; Aase A
Mol Immunol; 1993 Jan; 30(1):35-45. PubMed ID: 8417373
[TBL] [Abstract][Full Text] [Related]
2. Antibody dependent cell-mediated cytotoxicity induced by chimeric mouse-human IgG subclasses and IgG3 antibodies with altered hinge region.
Michaelsen TE; Aase A; Norderhaug L; Sandlie I
Mol Immunol; 1992 Mar; 29(3):319-26. PubMed ID: 1557042
[TBL] [Abstract][Full Text] [Related]
3. Alteration of the conformation of human IgG subclasses by reduction of the hinge S-S bonds.
Michaelsen TE
Mol Immunol; 1988 Jul; 25(7):639-46. PubMed ID: 3419438
[TBL] [Abstract][Full Text] [Related]
4. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.
Lucisano Valim YM; Lachmann PJ
Clin Exp Immunol; 1991 Apr; 84(1):1-8. PubMed ID: 1707767
[TBL] [Abstract][Full Text] [Related]
5. Development of two murine monoclonal antibodies recognizing human nG1m(a)-like isoallotypic markers.
Hajighasemi F; Khoshnoodi J; Shokri F
Hybridoma (Larchmt); 2008 Dec; 27(6):473-9. PubMed ID: 19108620
[TBL] [Abstract][Full Text] [Related]
6. Amino acid differences in the N-terminus of C(H)2 influence the relative abilities of IgG2 and IgG3 to activate complement.
Sensel MG; Kane LM; Morrison SL
Mol Immunol; 1997 Oct; 34(14):1019-29. PubMed ID: 9488053
[TBL] [Abstract][Full Text] [Related]
7. Structural difference in the complement activation site of human IgG1 and IgG3.
Michaelsen TE; Sandlie I; Bratlie DB; Sandin RH; Ihle O
Scand J Immunol; 2009 Dec; 70(6):553-64. PubMed ID: 19906198
[TBL] [Abstract][Full Text] [Related]
8. Fasciola hepatica: parasite-secreted proteinases degrade all human IgG subclasses: determination of the specific cleavage sites and identification of the immunoglobulin fragments produced.
Berasain P; Carmona C; Frangione B; Dalton JP; Goñi F
Exp Parasitol; 2000 Feb; 94(2):99-110. PubMed ID: 10673346
[TBL] [Abstract][Full Text] [Related]
9. The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies.
Lewis MJ; Wagner B; Woof JM
Mol Immunol; 2008 Feb; 45(3):818-27. PubMed ID: 17669496
[TBL] [Abstract][Full Text] [Related]
10. Human IgG subclass pattern of inducing complement-mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentration.
Michaelsen TE; Garred P; Aase A
Eur J Immunol; 1991 Jan; 21(1):11-6. PubMed ID: 1703960
[TBL] [Abstract][Full Text] [Related]
11. Removal of terminal alpha-galactosyl residues from xenogeneic porcine endothelial cells. Decrease in complement-mediated cytotoxicity but persistence of IgG1-mediated antibody-dependent cell-mediated cytotoxicity.
Watier H; Guillaumin JM; Piller F; Lacord M; Thibault G; Lebranchu Y; Monsigny M; Bardos P
Transplantation; 1996 Jul; 62(1):105-13. PubMed ID: 8693523
[TBL] [Abstract][Full Text] [Related]
12. Interaction of K lymphocytes with myeloma proteins of different IgG subclasses.
Spiegelberg HL; Perlmann H; Perlmann P
J Immunol; 1976 Nov; 117(5 Pt 1):1464-71. PubMed ID: 1002986
[TBL] [Abstract][Full Text] [Related]
13. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.
Bindon CI; Hale G; Brüggemann M; Waldmann H
J Exp Med; 1988 Jul; 168(1):127-42. PubMed ID: 3260935
[TBL] [Abstract][Full Text] [Related]
14. Human/mouse chimeric monoclonal antibodies with human IgG1, IgG2, IgG3 and IgG4 constant domains: electron microscopic and hydrodynamic characterization.
Phillips ML; Tao MH; Morrison SL; Schumaker VN
Mol Immunol; 1994 Oct; 31(15):1201-10. PubMed ID: 7935507
[TBL] [Abstract][Full Text] [Related]
15. The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region.
Canfield SM; Morrison SL
J Exp Med; 1991 Jun; 173(6):1483-91. PubMed ID: 1827828
[TBL] [Abstract][Full Text] [Related]
16. Opsonophagocytic and bactericidal activity mediated by purified IgG subclass antibodies after vaccination with the Norwegian group B meningococcal vaccine.
Aase A; Høiby EA; Michaelsen TE
Scand J Immunol; 1998 Apr; 47(4):388-96. PubMed ID: 9600322
[TBL] [Abstract][Full Text] [Related]
17. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.
Liu F; Bergami PL; Duval M; Kuhrt D; Posner M; Cavacini L
AIDS Res Hum Retroviruses; 2003 Jul; 19(7):597-607. PubMed ID: 12908937
[TBL] [Abstract][Full Text] [Related]
18. Solution structures of human myeloma IgG3 antibody reveal extended Fab and Fc regions relative to the other IgG subclasses.
Spiteri VA; Goodall M; Doutch J; Rambo RP; Gor J; Perkins SJ
J Biol Chem; 2021 Sep; 297(3):100995. PubMed ID: 34302810
[TBL] [Abstract][Full Text] [Related]
19. In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D.
Kumpel BM
Vox Sang; 1997; 72(1):45-51. PubMed ID: 9031501
[TBL] [Abstract][Full Text] [Related]
20. The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.
Hadley AG; Zupanska B; Kumpel BM; Leader KA
Immunology; 1992 Jul; 76(3):446-51. PubMed ID: 1356095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
